Prostate News Archive
05-Oct-2006
Spectrum says prostate drug promising in mid-stage (Reuters via Yahoo! Asia News)
NEW YORK (Reuters) - Spectrum Pharmaceuticals Inc. said on Tuesday its experimental drug to treat noncancerous enlarged prostate was highly effective in reducing symptoms associated with the condition called benign prostate hypertrophy (BPH) in a mid-stage clinical trial. Androgen-sensitive Prostate Cancer Survival And Progression Is Supported By Neuroendocrine Prostate Cancer Cells (Medical News Today)
Dr. Christopher Evans, University of California, Davis School of Medicine presented data showing that androgen insensitive prostate cancer cells can secrete neuropeptides that support the growth and migration of androgen sensitive prostate cancer cells in the castrate environment. Neuroendocrine (NE) cells are present in all developing and adult normal prostates. [click link for full article] New Prostate Cancer Marker Helps Identify Men Whose Cancer Is Likely To Spread (Science Daily)
Prostate cancer researchers at Sydney's Garvan Institute, supported by the Cancer Institute NSW, have found a new marker for identifying aggressive prostate cancers. Test Could Spot Aggressive Prostate Cancer (MedicineNet.com)
Title: Test Could Spot Aggressive Prostate Cancer Category: Health News Created: 10/4/2006 8:45:00 AM Last Editorial Review: 10/4/2006 8:45:25 AM Gene clues to help fight prostate cancer (Sydney Morning Herald)
A gene which gives men with prostate cancer a life-saving clue about whether their disease will spread has been uncovered by Australian scientists. -
Back to Prostate News Archive
